
    
      Determine if high frequency loading intravitreal pegaptanib will reduce the area and/or
      volume of DME, as assessed by Spectral Domain optical coherence tomography (SD-OCT) and to
      determine if this loading with gradual taper schedule of intravitreal pegaptanib will reduce
      the need for macular laser treatment.
    
  